Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
1.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.4K
1.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.2K
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AI-based methods for the assessment of DNA damage and repair mechanisms.

Frontiers in systems biology·2026
Same author

Sequence modeling tools to decode the biosynthetic diversity of the human microbiome.

mSystems·2025
Same author

Determination of the latent geometry of atorvastatin pharmacokinetics by transfer entropy to identify bottlenecks.

BMC pharmacology & toxicology·2025
Same author

Metabolic Engineering of <i>E. coli</i> for Enhanced Diols Production from Acetate.

ACS synthetic biology·2025
Same author

Characterization of gut microbiota dynamics in an Alzheimer's disease mouse model through clade-specific marker-based analysis of shotgun metagenomic data.

Biology direct·2024
Same author

PRONTO-TK: a user-friendly PROtein Neural neTwOrk tool-kit for accessible protein function prediction.

NAR genomics and bioinformatics·2024
Same journal

Mapping the 3D Chromosome Organization of a Biosynthetic Gene Cluster by Capture Hi-C (CHi-C).

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Mapping the 3D Chromosome Organization of Streptomyces by Hi-C.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

CUT&Tag Epigenomic Profiling of Biosynthetic Gene Clusters in Arabidopsis thaliana.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Rhizobium rhizogenes-Mediated Hairy Root Transformation Protocol for Lotus japonicus and Other Legumes.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Characterization of Bioactive Saponins from Sea Cucumbers.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Methods for Functional Validation of Terpenoid Metabolic Clusters in Nicotiana benthamiana and Aspergillus oryzae.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Related Experiment Video

Updated: Mar 12, 2026

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.7K

Network-Oriented Approaches to Anticancer Drug Response.

Paola Lecca1,2, Angela Re3

  • 1Department of Mathematics, University of Trento, via Sommarive 14, 38123, Povo Trento, Italy.

Methods in Molecular Biology (Clifton, N.J.)
|November 4, 2016
PubMed
Summary
This summary is machine-generated.

The traditional "one gene, one drug, one disease" model in drug discovery often fails due to biological system robustness. Network-based approaches offer a more effective systems-oriented strategy for drug design and identifying drug sensitivity signatures.

Keywords:
Biological network inferenceCancer systems biologyDrug discoveryDrug–target networksNetwork vulnerability analysis

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

11.2K
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

14.4K

Related Experiment Videos

Last Updated: Mar 12, 2026

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.7K
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

11.2K
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

14.4K

Area of Science:

  • Systems Biology
  • Genomics
  • Pharmacology

Background:

  • The traditional drug discovery paradigm focuses on single targets, often leading to suboptimal drug efficacy and side effects.
  • Biological systems exhibit inherent robustness, influencing drug sensitivity and resistance.
  • Advances in systems biology and genomic profiling necessitate a shift towards more holistic approaches.

Purpose of the Study:

  • To explore systems-oriented approaches in drug discovery.
  • To highlight the role of biological system robustness in drug response.
  • To introduce network-based methods for identifying drug sensitivity and resistance signatures.

Main Methods:

  • Analysis of successful and failed drug data.
  • Application of systems biology principles.
  • Utilizing high-throughput genomic profiling.
  • Employing network analysis and inference techniques.

Main Results:

  • Biological system robustness is a key determinant of drug sensitivity.
  • Network-based approaches can identify multi-feature signatures for drug response.
  • Systems-oriented drug design addresses the complexity of drug interactions.

Conclusions:

  • Network pharmacology and systems-oriented approaches are crucial for modern drug discovery.
  • Understanding system robustness is vital for predicting drug efficacy and resistance.
  • Network analysis provides a powerful framework for designing more effective multi-drug therapies.